Examples of 'ciclesonide' in a sentence
Meaning of "ciclesonide"
ciclesonide (noun): A type of medication used to treat asthma and allergic rhinitis by reducing inflammation in the airways
Show more definitions
- A glucocorticoid used to treat asthma and allergic rhinitis.
How to use "ciclesonide" in a sentence
Basic
Advanced
ciclesonide
A further example of a suitable corticosteroid is ciclesonide or flunisolide.
Ciclesonide is a glucocorticoid used to treat obstructive airway disease.
The vial is placed in an ultrasonic bath to ensure solubilisation of ciclesonide.
Ciclesonide is a newly generated lipophilic corticoid.
Combination of azelastine and ciclesonide.
Ciclesonide migrates to the bubbles formed at this time.
Pharmaceutical formulation comprising ciclesonide.
Use of ciclesonide for the treatment of respiratory diseases.
Process for preparing crystalline ciclesonide with defined particle size.
Ciclesonide for the treatment of airway disease in horses.
Such formulation generally comprises ethanol in an amount effective to solubilize the ciclesonide.
Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis.
The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis.
Ciclesonide will be suspended afterwards.
Alvesco ® contains the medicinal ingredient ciclesonide.
See also
In one embodiment ciclesonide is provided in a form suitable for inhalation.
In a preferred embodiment of the invention, said corticosteroid is ciclesonide.
Ciclesonide versus placebo for chronic asthma in adults and children.
Pharmaceutical formulation of ciclesonide obtainable by a method according to claims 4 to 7.
Ciclesonide has been described for use in the treatment of respiratory diseases.
Pharmaceutical formulation of ciclesonide comprising / containing.
Preferably ciclesonide is dispersed in the aqueous medium in form of solid particles.
A process according to claim 1 for the preparation of ciclesonide.
Preferably ciclesonide is contained in a core formulation releasing the drug substance immediately.
According to the invention, the name ciclesonide also includes solvates of ciclesonide.
For ciclesonide low systemic side effects have been observed in clinical studies.
When present in an aqueous medium, ciclesonide is resistant to wetting and easily aggregates.
Ciclesonide is a prodrug.
A pharmaceutical formulation which comprises azelastine, or a pharmaceutically acceptable salt, and ciclesonide.
Then the residual ciclesonide amount was calculated by administered ciclesonide amount and collected ciclesonide amount.
In certain other embodiments, the composition of the present invention comprises ciclesonide.
In another embodiment, ciclesonide or fluticasone or mometasone is selected.
Even more preferred are budesonide, beclomethasone dipropionate, mometasone furoate, ciclesonide and fluticasone propionate.
Ciclesonide exhibits low binding affinity to the glucocorticoid-receptor.
Preferred glucocorticoids according to the present invention are ciclesonide and / or budesonide and / or fluticasone.
A low dose of ciclesonide in a hypotonic watery suspension in combination with a topical antihistamine e . g.
Method of preparing the pharmaceutical formulation of ciclesonide according to claim 1 comprising the following steps,.
Ciclesonide is a novel inhaled corticosteroid for asthma treatment, which is undergoing clinical evaluation.
Process according to Claim 8, characterized in that the compound of formula I is ciclesonide.
Ciclesonide - known as trade name Omnaris.
Preferably, the steroid is budesonide, fluticasone or ciclesonide.
Each canister of ciclesonide aerosol is designed to provide 60 inhalations.
Each spray of unscented aqueous suspension delivers 50 µg ciclesonide.
Ciclesonide active metabolite:.
Deaggregate lactose monohydrate, formoterol fumarate dihydrate, and ciclesonide ( separately ).
Ciclesonide is a non-halogenated glucocorticoid, which predominantly exists in its form as R-Enantiomer.
Pharmaceutical formulation comprising / containing ciclesonide as active substance obtainable by a method according to claims 9 to 12.
These compounds do not present significant systemic absorption, with values under 1 %, together with ciclesonide.
Both ciclesonide doses resulted in comparable FEV1 values at 12 weeks.
A pharmaceutical composition as claimed in Claim 2 comprising from 1 to 8 mg / ml of ciclesonide.
